FDA Inspection
Gimopharm SarlGimopharm Sarl – FDA Inspection, Jul 30, 2019
Record Details
This FDA Inspection record concerns Gimopharm Sarl, with an inspection on July 30, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a8fffe8f-6f78-4d43-94cc-d882b4642fb8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1097970
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)(7)Identification of Person Performing the Testing
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Gimopharm Sarl
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 6, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gimopharm Sarl
- FDA Inspection 883308 - 2014-06-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.